Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

 Table of Contents  
BRIEF REPORT
Year : 2009  |  Volume : 5  |  Issue : 1  |  Page : 36-40

Importance of contouring the cervical spine levels in initial intensity-modulated radiation therapy radiation for head and neck cancers: Implications for re-irradiation


1 Department of Radiation Oncology, Weill Cornell Medical Center, New York, NY 10021, USA
2 Department of Otolaryngology, Weill Cornell Medical Center, New York, NY 10021, USA

Date of Web Publication17-Mar-2009

Correspondence Address:
Bhupesh Parashar
Stich Radiation Center, Weill Cornell Medical Center, New York, NY 10021
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0973-1482.48767

Rights and Permissions
 > Abstract 

Aim: To evaluate the maximum differential cervical spinal (C-spine) cord dose in intensity-modulated radiation therapy (IMRT) plans of patients undergoing radiotherapy for treatment of head and neck cancer.
Materials and Methods: The C-spine of ten head and neck cancer patients that were planned using IMRT and each cervical vertebral body and the right and left sides was contoured by splitting the cord in the center. Dose-volume histograms (DVH) and maximum point doses were obtained for each contour and compared.
Results: The dose to the cord varied with the location of the primary tumor but such variation was not consistently seen. This report provides information that is critical for planning reirradiation treatments. We recommend that contouring of the C-spine cord with IMRT should include outlining of each cervical cord level and identification of the right and the left sides of the cord on each plan.

Keywords: Cervical, contouring, cord, intensity-modulated radiation therapy, radiation


How to cite this article:
Parashar B, Kuo C, Kutler D, Kuhel W, Sabbas A, Wernicke G, Nori D. Importance of contouring the cervical spine levels in initial intensity-modulated radiation therapy radiation for head and neck cancers: Implications for re-irradiation. J Can Res Ther 2009;5:36-40

How to cite this URL:
Parashar B, Kuo C, Kutler D, Kuhel W, Sabbas A, Wernicke G, Nori D. Importance of contouring the cervical spine levels in initial intensity-modulated radiation therapy radiation for head and neck cancers: Implications for re-irradiation. J Can Res Ther [serial online] 2009 [cited 2020 Dec 2];5:36-40. Available from: https://www.cancerjournal.net/text.asp?2009/5/1/36/48767


 > Introduction Top


Intensity-modulated radiation therapy (IMRT) is a widely-utilized new modality for delivering a highly conformal dose of radiation to patients with cancers of the head and neck. One advantage of treatment with IMRT is the sparing of the parotid and the normal mucosa. IMRT may also provide improved local control and reduction in late complications. [1] However, locoregional recurrence remains a problem in head and neck cancers, especially in locally advanced cases. [2] Treatment options for patients with a locally recurrent cancer include surgical resection (with or without postoperative radiation) and chemotherapy. [3] In locally recurrent but unresectable disease definitive radiation, with or without chemotherapy, can be offered. [4] In patients who have received a prior full course of radiation, chemotherapy was traditionally offered as the sole treatment option because of the risk of injury to such critical structures as the spinal cord and brainstem. [4] The response rate of recurrent head and neck tumors to chemotherapy alone is poor, with a median survival of only a few months. [5] However, with the advent of IMRT, a full course of reirradiation is possible because it allows highly conformal treatment; moreover, reirradiation with IMRT may render cure. [6]

Conventional radiation treatment plans using three-dimensional (3D) or two-dimensional (2D) planning systems document the maximum radiation dose delivered to each critical organ. For example, the tolerance limit of the spinal cord is usually considered to be 45-50 Gray (Gy), [7] though there are data to suggest that the cord may tolerate higher doses. [8] In a non-IMRT plan (i.e., 2D or 3D plans), the C-spine gets a fairly uniform dose. However, only limited additional radiation can be added since the entire C-spine would have received, or is presumed to have received, the maximum permissible dose. This is not true for IMRT plans, where the dose distribution is not uniform and some areas of the cervical cord may receive a significantly higher dose than other sites. This dose disparity has significant implications for the treatment of patients who present with locally recurrent disease or a second primary in the head and neck area. In fact, the cord dose close to the site of recurrence may determine the total final reirradiation dose that can be delivered to these patients. In this study, we wanted to evaluate the differential C-spine cord dose with IMRT treatment to patients with head and neck cancer after contouring each cervical cord level (using cervical vertebrae), as well as dividing each level into right and left sides.


 > Materials and Methods Top


Ten patients who had previously received radiation to the head and neck area were included in the study. An IMRT plan and dose-volume histograms (DVH0 were generated for each patient. The dose prescriptions were given for each patient according to the volume and extent of disease. Four patients received a total dose of 70 Gy, in 2 Gy per fraction, to gross disease. Areas at high risk for microscopic disease received 60-63 Gy at 1.8 Gy per fraction and areas at lower risk of microscopic disease received 50-56 Gy at 1.8-1.6 Gy per fraction. One patient received an IMRT boost to his nasopharynx primary to a dose 20 Gy at 2 Gy per fraction. Three patients (two postoperative oral cavity primaries and one tonsillar primary) received ipsilateral neck radiation. The maximum permissible dose to any level of spinal cord was 50 Gy in nine of ten patients, whether treatment was for a primary tumor or for recurrent disease. One patient received definitive reirradiation (3 rd course of radiation) to the nasopharynx and the cumulative point dose (<1% of volume) to a part of the cervical cord was ~51 Gy. Eight of the ten patients received chemotherapy concurrently with radiation.

The C-spine of each patient was contoured by the same physician, with a separate contour generated for each cervical vertebral body [Figure 1]. In addition, the right and left sides of each vertebral body were also specified by splitting the cord in the center. A DVH and maximum point dose were obtained for each contour.

The patient characteristics are outlined in [Table 1].

The study was done in after obtaining the institutional review board's approval and in accordance with its guidelines.


 > Results Top


For each of the ten patients, the radiation doses to all cervical cord levels, left and right side, were normalized to the maximum cord dose [Table 2] and [Figure 2A],[Figure 2B],[Figure 2C],[Figure 2D],[Figure 2E],[Figure 2F],[Figure 2G],[Figure 2H],[Figure 2I],[Figure 2J],. In patients who received radiation to the primary site of disease as well as the neck, the doses to cervical cord levels ranged from 63 to 100% of maximum cord dose. In two patients, one of whom was planned for IMRT boost treatment only and the other for radiation to the primary site only (patient #4 and #5, respectively) [Table 1], the dose range was significantly larger among between the cord levels (4-100%). The cord dose varied between vertebral bodies and was dependant on the location of the primary tumor as well as other high-risk areas. Cervical cord levels located in the vicinity of the high-dose area received a higher maximum dose compared to the cervical cord levels that were situated away from that region, though such variation was not consistently seen. For example, in patient #1 who had a left-sided primary tonsil cancer, the maximum dose was to the left cervical cord levels [Table 2], patient 1, C1-C6. Overall, for all patients, the range of normalized cord doses to different sections of the cervical cord varied from 4 to 100%.

Patients who were treated only to the primary site using IMRT plan (i.e., no radiation to the nodal areas) had most of the C-spine cord levels spared from the high radiation dose, except for the region that was in the immediate vicinity of the primary tumor [Table 2], patient #4 and #5. Patients #9 and #10 had ipsilateral (right) neck radiation; however, the dose to the left side of cervical cord was not significantly lower than that to the right side, except for the lower cervical cord levels [Table 2]; [Figure 2I] and [Figure 2J].


 > Discussion Top


As demonstrated in our study, different levels of the C-spine cord receive significantly different doses of radiation if IMRT techniques are employed. The normal output of a treatment planning system includes dose statistics (maximum, minimum, and mean dose) and the DVHs for various regions of interest. This information, although useful, does not convey the much needed spatial information as to the location of the hot spots in the C-spine cord. By separately outlining the various levels of the C-spine, we can more effectively assess the radiation doses along the cervical vertebrae and isolate the hot spots.

This finding has important implications in patients who may require reirradiation for locally recurrent disease. If a patient develops recurrent disease in an area where the cord received less than 95% of the maximum tolerated cord dose then, in our experience, a highly conformal reirradiation plan can be generated that can provide definitive/curative high radiation doses. On the other hand, one should not make an assumption regarding the cord dose on the contralateral side of the cord for patients receiving ipsilateral radiation since the contralateral side may have also received a significant radiation dose with an IMRT plan.

Since this information is critical in planning reirradiation treatments, we recommend that contouring of the cervical cord for any IMRT plan should include outlining of each cervical cord level and identification of the right and the left sides in each plan. For patients who have received primary IMRT for their head and neck malignancy in another institution, this information becomes even more relevant since it may be difficult to review dose distribution for each CT slice of primary treatment planning. We submit that introducing assessment of the maximum differential C-spine dose, using the contouring method of each cervical cord level and evaluating the right and the left sides separately, may make reirradiation safer and more effective.

 
 > References Top

1.Lee N, Xia P, Quivey JM, Sultanem K, Poon I, Akazawa C, et al . Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002;53:12-22.  Back to cited text no. 1
[PUBMED]  [FULLTEXT]  
2.Brockstein B, Haraf DJ, Rademaker AW, Kies MS, Stenson KM, Rosen F, et al . Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: A 9-year, 337-patient, multi-institutional experience. Ann Oncol 2004;15:1179-86.  Back to cited text no. 2
[PUBMED]  [FULLTEXT]  
3.Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ, Million RR. Salvage surgery following radiation failure in squamous cell carcinoma of the supraglottic larynx. Int J Radiat Oncol Biol Phys 1995;32:605-9.  Back to cited text no. 3
[PUBMED]  [FULLTEXT]  
4.Creak AL, Harrington K, Nutting C. Treatment of recurrent head and neck cancer: Re-irradiation or chemotherapy? Clin Oncol (R Coll Radiol) 2005;17:138-47.  Back to cited text no. 4
[PUBMED]    
5.Forastiere AA, Shank D, Neuberg D, Taylor SG 4th, DeConti RC, Adams G. Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: An Eastern Cooperative Oncology Group trial (PA390). Cancer 1998;82:2270-4.  Back to cited text no. 5
[PUBMED]  [FULLTEXT]  
6.Lee N, Chan K, Bekelman JE, Zhung J, Mechalakos J, Narayana A, et al . Salvage re-irradiation for recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 2007;68:731-40.  Back to cited text no. 6
[PUBMED]  [FULLTEXT]  
7.Spencer SA, Harris J, Wheeler RH, Machtay M, Schultz C, Spanos W, et al . RTOG 96-10: Reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys 2001;51:1299-304.  Back to cited text no. 7
[PUBMED]  [FULLTEXT]  
8.Nieder C, Grosu AL, Andratschke NH, Molls M. Proposal of human spinal cord reirradiation dose based on collection of data from 40 patients. Int J Radiat Oncol Biol Phys 2005;61:851-5.  Back to cited text no. 8
[PUBMED]  [FULLTEXT]  


    Figures

  [Figure 1], [Figure 2A], [Figure 2B], [Figure 2C], [Figure 2D], [Figure 2E], [Figure 2F], [Figure 2G], [Figure 2H], [Figure 2I], [Figure 2J]
 
 
    Tables

  [Table 1], [Table 2]


This article has been cited by
1 Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy
Ying Sun,Xiao-Li Yu,Wei Luo,Anne W.M. Lee,Joseph Tien Seng Wee,Nancy Lee,Guan-Qun Zhou,Ling-Long Tang,Chang-Juan Tao,Rui Guo,Yan-Ping Mao,Rong Zhang,Ying Guo,Jun Ma
Radiotherapy and Oncology. 2014; 110(3): 390
[Pubmed] | [DOI]
2 Regional cumulative maximum dose to the spinal cord in head-and-neck cancer: Considerations for re-irradiation
Stoiber, E.M. and Schwarz, M. and Debus, J. and Huber, P.E. and Bendl, R. and Giske, K.
Radiotherapy and Oncology. 2013; 106(1): 96-100
[Pubmed]
3 Regional cumulative maximum dose to the spinal cord in head-and-neck cancer: Considerations for re-irradiation
Eva M. Stoiber,Michael Schwarz,Jürgen Debus,Peter E. Huber,Rolf Bendl,Kristina Giske
Radiotherapy and Oncology. 2013; 106(1): 96
[Pubmed] | [DOI]
4 6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, Switzerland
Beck, A., Wurch, T., Reichert, J.M.
mAbs. 2011; 3(2): 111-134
[Pubmed]
5 Experimental study of radioimmunotherapy versus chemotherapy for colorectal cancer
De Jong, G.M., Bleichrodt, R.P., Eek, A., Oyen, W.J.G., Boerman, O.C., Hendriks, T.
British Journal of Surgery. 2011; 98(3): 436-441
[Pubmed]
6 Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodies
Boudousq, V., Ricaud, S., Garambois, V., Bascoul-Mollevi, C., Boutaleb, S., Busson, M., Quenet, F., (...), Pouget, J.-P.
Journal of Nuclear Medicine. 2010; 51(11): 1748-1755
[Pubmed]
7 New antibody conjugates in cancer therapy
Govindan, S.V., Goldenberg, D.M.
TheScientificWorldJournal. 2010; 10: 2070-2089
[Pubmed]
8 A rapid microwave-assisted procedure for easy access to Npolydentate ligands for potential application in α-RIT
Mével, M., Bodio, E., Grosjean, S., Montavon, G., Meslin, J.-C., Julienne, K., Deniaud, D.
Synlett. 2010; 8: 1215-1218
[Pubmed]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

  >Abstract>Introduction>Materials and Me...>Results>Discussion>Article Figures>Article Tables
  In this article
>References

 Article Access Statistics
    Viewed3814    
    Printed186    
    Emailed2    
    PDF Downloaded429    
    Comments [Add]    
    Cited by others 8    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]